「in vitroinvivoin vitroinvivo」の検索結果
162件：106～110件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
2) 井上幸次3) 1) 愛媛大学医学部眼科学教室 2)千寿製薬株式会社 3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Ho...
http://www.senju.co.jp/chinese/rd/thesis/ -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju ...
http://www.senju.co.jp/english/about/philosophy.html -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju ...
https://www.senju.co.jp/english/about/philosophy.html -
学会发表 | 研究与开发 | 千寿制药株式会社
more 海外 AAO 2025 開催日：2025年10月17日～2025年10月20日 開催地：Orlando, FL, USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Stu...
http://www.senju.co.jp/chinese/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Overseas AAO 2025 開催日：2025年10月17日～2025年10月20日 開催地：Orlando, FL, USA Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Stu...
https://www.senju.co.jp/english/rd/society/